AU1794397A - Use of alpha1-adrenoceptor antagonists - Google Patents

Use of alpha1-adrenoceptor antagonists

Info

Publication number
AU1794397A
AU1794397A AU17943/97A AU1794397A AU1794397A AU 1794397 A AU1794397 A AU 1794397A AU 17943/97 A AU17943/97 A AU 17943/97A AU 1794397 A AU1794397 A AU 1794397A AU 1794397 A AU1794397 A AU 1794397A
Authority
AU
Australia
Prior art keywords
alpha1
adrenoceptor antagonists
adrenoceptor
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17943/97A
Inventor
Luigia Ventura Gregorini
Norbert Kolassa
Karl Sanders
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Byk Gulden Lomberg Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik GmbH filed Critical Byk Gulden Lomberg Chemische Fabrik GmbH
Publication of AU1794397A publication Critical patent/AU1794397A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU17943/97A 1996-02-28 1997-02-22 Use of alpha1-adrenoceptor antagonists Abandoned AU1794397A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19607487 1996-02-28
DE1996107487 DE19607487C2 (en) 1996-02-28 1996-02-28 Use of alpha1 adrenoceptor antagonists
PCT/EP1997/000861 WO1997031638A1 (en) 1996-02-28 1997-02-22 USE OF α1-ADRENOCEPTOR ANTAGONISTS

Publications (1)

Publication Number Publication Date
AU1794397A true AU1794397A (en) 1997-09-16

Family

ID=7786662

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17943/97A Abandoned AU1794397A (en) 1996-02-28 1997-02-22 Use of alpha1-adrenoceptor antagonists

Country Status (3)

Country Link
AU (1) AU1794397A (en)
DE (1) DE19607487C2 (en)
WO (1) WO1997031638A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101176699B1 (en) 2006-10-19 2012-08-23 에프. 호프만-라 로슈 아게 Aminomethyl-4-imidazoles

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2626176A1 (en) * 1988-01-25 1989-07-28 Baligadoo Soorianarain Cardioprotective medicinal preparations comprising amiodarone, a nitro derivative and optionally a beta-blocker
JPH05504136A (en) * 1990-02-01 1993-07-01 ビイク　グルデン　ロンベルク　ヒエーミツシエ　フアブリーク　ゲゼルシヤフト　ミツト　ベシユレンクテル　ハフツング Use of substituted uracil

Also Published As

Publication number Publication date
DE19607487C2 (en) 1998-09-10
DE19607487A1 (en) 1997-09-04
WO1997031638A1 (en) 1997-09-04

Similar Documents

Publication Publication Date Title
AU2524995A (en) Neurokinine (tachykinine) antagonists
AU3899997A (en) Muscarinic antagonists
AU5752398A (en) Novel ketobenzamides and their use
AU7645496A (en) Roundsling construction
AU6856796A (en) Des-arg9-bk antagonists
AU4251197A (en) Therapeutic chemokine antagonists
AU3905197A (en) Toothbrush construction
AU3620297A (en) Substituted triazoloazinesulphonamides
AU4224096A (en) Use of phenylcyclohexylcarboxamides
HU9702480D0 (en) New polymorphe modification of doxazosin-mesylate
AU3771497A (en) Substituted p-trifluoromethylphenyluracils
CY2590B2 (en) Preparation of 1-butyl-4-piperidinylmethylamine
AU4422897A (en) Cross-dimerization of olefins
GB9602704D0 (en) Structure of perculator
AU1926397A (en) Substituted 1-methyl-3-benzyluracils
AU3116697A (en) Human interleukin-1j and antagonists thereof
HU9702479D0 (en) New polymorphe modification of doxazosin-mesylate
AU1846397A (en) Prolactin antagonists and uses thereof
AUPO118896A0 (en) New use
AU8333998A (en) New use of nociceptin
AU3935897A (en) B1-bradykinin receptor antagonists and use thereof
AU2152497A (en) Heterocyclic compounds and their preparation and use
AU2595297A (en) Use of aminoalkylcarboxylic derivatives
AUPO440696A0 (en) New use
AU1794397A (en) Use of alpha1-adrenoceptor antagonists